News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Editas Medicine
NEWS
JOBS
IN THE PRESS
AWARDS
NEWS
Drug Development
CRISPR, Editas Medicine and Intellia Fall as Scientific Paper Warns of Unintended Mutations Linked to Gene-Editing
May 31, 2017
·
3 min read
Business
Is Editas Medicine Facing A New Reality In CRISPR Land?
May 17, 2017
·
1 min read
Business
Editas Medicine, Veritas Genetics Co-Founder and Biotech Phenom George Church Makes Time’s 100 ‘Most Influential’ List
April 21, 2017
·
2 min read
Business
Turns Out Editas Medicine’s R&D Deal With Allergan Could be Worth $1 Billion
March 23, 2017
·
3 min read
Business
Third Rock Ventures Quietly Launches Tango Therapeutics in Editas Medicine’s HQ
March 7, 2017
·
2 min read
Business
COO and First Employee of Editas Medicine to Exit, Effective March 31
March 6, 2017
·
2 min read
Business
Editas Medicine Brings on New Execs From Sanofi Genzyme, Novartis AG, Baxalta and Bristol-Myers Squibb
October 5, 2016
·
2 min read
Biotech Bay
10 Biotech Stocks Analysts are Upbeat About in May
May 23, 2016
·
3 min read
Bio NC
Top 5 Biotech Winners and Losers of Q1 2016
March 31, 2016
·
3 min read
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
Editas Medicine Announces Third Quarter 2025 Results and Business Updates
November 10, 2025
·
9 min read
Press Releases
Editas Medicine Announces EDIT-401 Poster Presentation at the American Heart Association (AHA) Scientific Sessions 2025
November 4, 2025
·
1 min read
Press Releases
Editas Medicine Reports In Vivo Proof-of-Concept Data for EDIT-401 at the European Society of Gene and Cell Therapy (ESGCT) 32nd Annual Congress
October 10, 2025
·
2 min read
Press Releases
Editas Medicine Announces EDIT-401 Oral Presentation at the European Society of Gene and Cell Therapy (ESGCT) 32nd Annual Congress and Participation in Upcoming Investor Conferences
October 7, 2025
·
2 min read
Press Releases
Editas Medicine Nominates EDIT-401, an LDLR-Targeted Medicine, as Lead In Vivo Development Candidate
September 3, 2025
·
7 min read
Press Releases
Editas Medicine to Host Webinar Announcing Lead In Vivo Development Candidate
August 29, 2025
·
1 min read
Press Releases
Editas Medicine to Participate in Upcoming September 2025 Investor Conferences
August 28, 2025
·
1 min read
Press Releases
Editas Medicine Announces Second Quarter 2025 Results and Business Updates
August 13, 2025
·
9 min read
Press Releases
Editas Medicine Reports Proprietary Targeted Lipid Nanoparticle Delivery in Non-Human Primates Enables In Vivo HBG1/2 Promoter Editing for Sickle Cell Disease and Beta Thalassemia at the European Hematology Association 2025 Congress in June
June 12, 2025
·
3 min read
Press Releases
Editas Medicine Reports New In Vivo Data Highlighting the Potential of Editas’ Gene Upregulation Strategy in HSCs at the American Society of Gene and Cell Therapy Annual Meeting
May 15, 2025
·
4 min read
